Nonmelanoma Facial Skin Carcinomas

Abstract

Metastatic lymph node involvement localized to the auricular, infra-auricular, and postauricular was present in the pathological specimens of all patients with lesions who had selective neck dissection I to IV included into their treatment. The depth of invasion of SCCs was found to be statistically significant in terms of recurrences.

Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta‐analysis

“…Studies included for analyses were published between 1957 and 2017; the number of included patients ranged from 40 to 6164 (Table ) . These studies were performed in the USA, New Zealand, Australia, The Netherlands, Denmark, the UK, Greece, Turkey and Israel.…”

“…Fourteen studies included patients with cSCC on the total body, six studies with patients with cSCC in the head and neck area . One study also included specified data on 10 OTR, that were excluded for this study as it were less than 25 patients …”

“…Studies included for analyses were published between 1957 and 2017; the number of included patients ranged from 40 to 6164 (Table 1). [22][23][24][25]30,44,47,[77][78][79][80][81][82][83][84][85][86][87][88][89] These studies were performed in the USA, New Zealand, Australia, The Netherlands, Denmark, the UK, Greece, Turkey and Israel. Median follow-up time ranged from 24 to 81 months.…”

“…Fourteen studies included patients with cSCC on the total body, [22][23][24]30,44,47,[78][79][80][81]83,84,87,88 six studies with patients with cSCC in the head and neck area. 25,77,82,85,86,89 One study also included specified data on 10 OTR, that were excluded for this study as it were less than 25 patients. 88 Two studies comparing immunocompetent population and OTR Both studies were performed in the USA and studied total body cSCC.…”

“…The majority of studies reported on consecutive cSCC in their patients during the study period, but seven did not. 24,30,52,54,83,85 Seven studies reported on loss of follow-up 30,45,50,57,81,82,86 with a loss of follow-up of more than 5% in 6/7. 30,45,50,57,81,86 One study excluded patients with follow-up less than 6 months, 50 and one study included only patients with a minimum followup of more than 1 year.…”